Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2014

Ausgabe 2/2014

Inhaltsverzeichnis ( 20 Artikel )

01.01.2014 | Editorial | Ausgabe 2/2014

What is the future of magnetic nanoparticles in the axillary management of breast cancer?

M. Ahmed, M. Douek

01.01.2014 | Review | Ausgabe 2/2014

The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer

Kathleen M. Sturgeon, Bonnie Ky, Joseph R. Libonati, Kathryn H. Schmitz

01.01.2014 | Preclinical Study | Ausgabe 2/2014

Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin

Dareen M. Abdelaziz, Laura S. Stone, Svetlana V. Komarova

01.01.2014 | Preclinical Study | Ausgabe 2/2014 Open Access

Inhibition of LINE-1 retrotransposon-encoded reverse transcriptase modulates the expression of cell differentiation genes in breast cancer cells

Radhika Patnala, Sung-Hun Lee, Jane E. Dahlstrom, Stephen Ohms, Long Chen, S. Thameem Dheen, Danny Rangasamy

01.01.2014 | Preclinical study | Ausgabe 2/2014

Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models

Huilian Bu, Bin Shu, Feng Gao, Cheng Liu, Xuehai Guan, Changbin Ke, Fei Cao, Antentor Othrell Hinton Jr., Hongbing Xiang, Hui Yang, Xuebi Tian, Yuke Tian

01.01.2014 | Preclinical study | Ausgabe 2/2014

CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

Subir Biswas, Suman Sengupta, Sougata Roy Chowdhury, Samir Jana, Gunjan Mandal, Palash Kumar Mandal, Nipun Saha, Vivek Malhotra, Arnab Gupta, Dmitry V. Kuprash, Arindam Bhattacharyya

01.01.2014 | Preclinical Study | Ausgabe 2/2014

Hyaluronan synthases (HAS1–3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival

Päivi Auvinen, Kirsi Rilla, Ritva Tumelius, Markku Tammi, Reijo Sironen, Ylermi Soini, Veli-Matti Kosma, Arto Mannermaa, Jukka Viikari, Raija Tammi

01.01.2014 | Preclinical study | Ausgabe 2/2014

Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo

Yunhui Hu, Shuangjing Li, Ming Yang, Cihui Yan, Dongmei Fan, Yuan Zhou, Yanjun Zhang, Ernesto Yagüe, Dongsheng Xiong

01.01.2014 | Preclinical study | Ausgabe 2/2014

Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells

Carolyn A. Goard, Michelle Chan-Seng-Yue, Peter J. Mullen, Ariel D. Quiroga, Amanda R. Wasylishen, James W. Clendening, Dorota H. S. Sendorek, Syed Haider, Richard Lehner, Paul C. Boutros, Linda Z. Penn

01.01.2014 | Clinical trial | Ausgabe 2/2014

Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience

José Pablo Leone, Julieta Leone, Carlos Teodoro Vallejo, Juan Eduardo Pérez, Alberto Omar Romero, Mario Raul Machiavelli, Luis Romero Acuña, María Ester Domínguez, Mario Langui, Hebe Margot Fasce, Bernardo Amadeo Leone, Eduardo Ortiz, Julián Iturbe, Ariel Osvaldo Zwenger

01.01.2014 | Clinical trial | Ausgabe 2/2014

A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure

Suleiman Massarweh, Edward Romond, Esther P. Black, Emily Van Meter, Brent Shelton, Vera Kadamyan-Melkumian, Mark Stevens, Richard Elledge

01.01.2014 | Clinical Trial | Ausgabe 2/2014

Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience

Floris P. R. Verbeek, Susan L. Troyan, J. Sven D. Mieog, Gerrit-Jan Liefers, Lorissa A. Moffitt, Mireille Rosenberg, Judith Hirshfield-Bartek, Sylvain Gioux, Cornelis J. H. van de Velde, Alexander L. Vahrmeijer, John V. Frangioni

01.01.2014 | Clinical Trial | Ausgabe 2/2014

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS)

Julia S. Wong, Yu-Hui Chen, Michele A. Gadd, Rebecca Gelman, Susan C. Lester, Stuart J. Schnitt, Dennis C. Sgroi, Barbara J. Silver, Barbara L. Smith, Susan L. Troyan, Jay R. Harris

01.01.2014 | Clinical trial | Ausgabe 2/2014 Open Access

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102

Julie R. Gralow, William E. Barlow, Danika Lew, Kim Dammann, George Somlo, Kristine J. Rinn, Stanley J. Vogel, Lucas Wong, Robert B. Livingston, Gabriel N. Hortobagyi

01.01.2014 | Epidemiology | Ausgabe 2/2014

Impact of full-field digital mammography on pre-operative diagnosis and surgical treatment of mammographic microcalcification

S. M. Bundred, J. Zhou, S. Whiteside, J. Morris, M. Wilson, E. Hurley, N. Bundred

01.01.2014 | Epidemiology | Ausgabe 2/2014

Breast cancer screening of women aged 70–74 years: results from a natural experiment across Australia

Carolyn Nickson, Kate E. Mason, Anne M. Kavanagh

01.01.2014 | Epidemiology | Ausgabe 2/2014 Open Access

Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer

Andrea Vodermaier, Wolfgang Linden, Katerina Rnic, Sandra N. Young, Alvina Ng, Nina Ditsch, Robert Olson

01.01.2014 | Brief Report | Ausgabe 2/2014

Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women

E. Tilch, T. Seidens, S. Cocciardi, L. E. Reid, D. Byrne, P. T. Simpson, A. C. Vargas, M. C. Cummings, S. B. Fox, S. R. Lakhani, G. Chenevix Trench

01.01.2014 | Brief Report | Ausgabe 2/2014

The role of genes co-amplified with nicastrin in breast invasive carcinoma

A. Sarajlić, A. Filipović, V. Janjić, R. C. Coombes, N. Pržulj

01.01.2014 | Brief Report | Ausgabe 2/2014

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

Mitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka, Tomohiro Nogami, Takayuki Motoki, Tadahiko Shien, Naruto Taira, Naoki Niikura, Naoki Hayashi, Shoichiro Ohtani, Kenji Higaki, Toshiyoshi Fujiwara, Hiroyoshi Doihara, W. Fraser Symmans, Lajos Pusztai

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise